-
Remdesivir and the Polymerase Frontier
2026-08-20
Remdesivir (GS-5734) offers translational researchers a practical bridge between nucleoside analogue pharmacology, RNA virus replication biology, and emerging polymerase structures. This article examines the evidence supporting its use in coronavirus and Ebola virus research, explains how Nipah virus polymerase architecture expands the strategic framework, and outlines disciplined workflows for interpreting potency without overextending the data.
-
SAF312 (Libvatrep): Ocular TRPV1 Pharmacology
2026-08-20
The reference study establishes an integrated preclinical profile for SAF312 (libvatrep), combining human ocular tissue expression, receptor pharmacology, ocular pharmacokinetics, toxicology, and corneal wound-healing analysis. Its findings support localized, selective TRPV1 antagonism as a potential strategy for ocular surface pain while defining the evidence and limitations that must be addressed before clinical translation.
-
Patient-Derived Gastric Cancer Assembloids Explained
2026-08-19
This 2025 study introduces patient-derived gastric cancer assembloids that combine matched tumor organoids with tumor-derived stromal subpopulations, including fibroblasts, mesenchymal stem cells, and endothelial cells. The model captures clinically relevant tumor–stroma effects on gene expression and drug response, providing a more physiologically informative platform for gastric cancer research and personalized treatment assessment.
-
Disulfiram Workflows for Proteasome and Cancer Research
2026-08-19
Disulfiram supports paired proteasome, apoptosis, and inflammasome experiments rather than a single-endpoint screening strategy. This guide translates its copper-sensitive activity and cancer-cell applications into practical workflows with controls, assay choices, and troubleshooting safeguards.
-
Y-27632: Practical ROCK Inhibitor Workflow Guide
2026-08-18
Y-27632 (SKU B1293) is a research-use ROCK inhibitor for controlled ROCK1/ROCK2 inhibition, cytoskeletal dynamics modulation, and cell stress fiber disruption. This guide focuses on dose and exposure planning, solvent handling, and assay QC; it should not be used to infer clinical efficacy, diagnostic performance, or universal behavior across cell types.
-
Cl-Amidine: PAD4 Assays Under Stress
2026-08-18
Cl-Amidine trifluoroacetate salt enables selective interrogation of PAD4 activity across biochemical, cancer, inflammatory, and septic shock models. This guide connects PAD4 assay design with ribotoxic-stress biology while separating direct evidence from testable hypotheses.
-
Molnupiravir and Bourbon Virus Disease in Mice
2026-08-17
The reference study provides a preclinical evaluation of molnupiravir against lethal Bourbon virus infection, combining antiviral, survival, hematologic, immune, and tissue-pathology endpoints in mice. Its findings support further investigation of an orally available nucleoside analogue while underscoring the need to validate efficacy across virus-specific models and treatment windows.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-17
Liu et al. identify a secretase-dependent Neuroligin 1 cleavage pathway in the ventral hippocampus that converts social interaction into a sustained intracellular signal. The resulting NLG1-CTD fragment engages PDZ-dependent cofilin signaling, promotes dendritic spine remodeling, and supports the maintenance of recently acquired social memories.
-
Metoprolol Tartrate in β1 Signaling Assays
2026-08-16
Metoprolol Tartrate gives researchers a selective way to separate cardiac β1-adrenergic signaling from broader β-blockade. Its water compatibility, defined purity, and utility in both cardiomyocyte assays and hematopoietic regeneration studies support controlled, mechanism-focused experimental designs.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-08-14
Inskeep and colleagues connect SMPD4-dependent ceramide production with primary cilia integrity, neural progenitor survival, and cerebellar development using mouse and human iPSC models. The rescue of SMPD4-deficient human cells by exogenous ceramide provides mechanistic support for a lipid–cilium pathway in severe neurodevelopmental disease.
-
Metronidazole: OAT3 Assay Workflows and Optimization
2026-08-14
Metronidazole supports two complementary research applications: mechanistic inhibition of human OAT3 and experimental targeting of anaerobic bacteria and protozoa. This workflow-focused guide explains concentration design, controls, preparation, and troubleshooting for more reproducible transporter, drug-drug interaction, and antimicrobial assays.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-13
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should be used as a secondary reagent for validated goat-IgG assays, not for direct detection or non-goat primary antibodies.
-
Capsaicin: TRPV1 and KDM1A Research Guide
2026-08-13
Capsaicin, also called (E)-Capsaicin, is a dual-mechanism research compound that activates the TRPV1 ion channel and inhibits KDM1A/LSD1. Its strongest mechanistic oncology evidence shows reversible KDM1A inhibition and reduced gastric cancer cell proliferation, migration, invasion, and EMT-associated behavior.
-
DPPH: From Radical Signal to Assay Decision
2026-08-12
DPPH provides a rapid colorimetric readout for in vitro antioxidant screening, but its greatest value lies in how results guide fractionation, orthogonal testing, and natural product decisions. This article connects DPPH chemistry with the multi-assay strategy used for Taihangia rupestris research.
-
Phebestin Targets Plasmodium Aminopeptidases
2026-08-12
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial candidate active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its stage-spanning activity, persistent effects after washout, computational interaction with PfM1AAP and PfM17LAP, and supportive mouse data provide a rationale for developing aminopeptidases as malaria drug targets.